PRESS RELEASE published on 05/06/2025 at 08:00, 10 months 16 days ago Amoéba obtains an exceptional exemption in the Netherlands for its biocontrol product AXPERA for large-scale greenhouse trials Amoéba obtained authorisation for trials of AXPERA in the Netherlands, allowing consumption of treated crops. The Dutch greenhouse market is a strategic showcase for showcasing AXPERA's value in biocontrol fungicide AMOEBA Biocontrol Netherlands AXPERA Greenhouse Market
BRIEF published on 04/22/2025 at 18:05, 11 months ago Autorisation d'urgence pour le produit AXPERA d'Amoéba en France AMOEBA Biocontrôle AXPERA Mildiou Vigne Autorisation Urgence
BRIEF published on 04/22/2025 at 18:05, 11 months ago Emergency authorization for Amoéba's AXPERA product in France AMOEBA Biocontrol AXPERA Vine Mildew Emergency Authorization
PRESS RELEASE published on 04/22/2025 at 18:00, 11 months ago Nouvelle avancée stratégique : Le produit de biocontrôle Axpéra obtient une autorisation de mise sur le marché d'urgence en France // Une nouvelle solution à l'efficacité démontrée contre le mildiou de la vigne Amoéba obtient une autorisation d'urgence pour AXPERA, biocontrôle pour lutter contre le mildiou de la vigne. Une étape avant l'autorisation permanente AMOEBA Biocontrôle Autorisation AXPERA Mildiou
PRESS RELEASE published on 04/22/2025 at 18:00, 11 months ago New strategic milestone for Amoéba: Axpéra biocontrol product receives emergency market authorisation in France // A proven new solution to help winegrowers combat grapevine downy mildew Amoéba receives emergency marketing authorization for AXPERA biocontrol product to combat grapevine downy mildew, helping French winegrowers against phytosanitary challenges AMOEBA Biocontrol AXPERA Emergency Authorization Grapevine Downy Mildew
BRIEF published on 04/17/2025 at 18:05, 11 months 5 days ago Amoéba publie son Document d'Enregistrement Universel 2024 AMOEBA AMF Rapport Financier Document D'enregistrement Gouvernement D'entreprise
BRIEF published on 04/17/2025 at 18:05, 11 months 5 days ago Amoéba publishes its 2024 Universal Registration Document AMOEBA AMF Financial Report Corporate Governance Registration Document
PRESS RELEASE published on 04/17/2025 at 18:00, 11 months 5 days ago Amoéba annonce la mise à disposition de son Document d'Enregistrement Universel 2024 Amoéba annonce le dépôt de son Document d'Enregistrement Universel 2024 auprès de l'AMF, incluant les rapports financiers et sur le gouvernement d'entreprise AMOEBA AMF GreenTech Solutions Microbiologiques Document D'Enregistrement Universel 2024
PRESS RELEASE published on 04/17/2025 at 18:00, 11 months 5 days ago Amoéba announces the publication of its Universal Registration Document 2024 Amoéba announces filing of 2024 Universal Registration Document with French Financial Markets Authority, including financial reports and corporate governance details AMOEBA French Financial Markets Authority GreenTech Microbiological Solutions 2024 Universal Registration Document
BRIEF published on 04/14/2025 at 08:50, 11 months 8 days ago AMOEBA: Initiation de Couverture par KBC Securities et Expansion Internationale AMOEBA Biocontrôle International Cosmétique KBC Securities
Published on 03/20/2026 at 13:30, 2 days 9 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 10 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 10 hours 12 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 23 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 1 hour ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 1 hour ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 3 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 3 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 4 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 4 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA